Results 81 to 90 of about 598,257 (319)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study

open access: yesFrontiers in Cardiovascular Medicine, 2022
ObjectiveTo quantify the association between ideal cardiovascular health (CVH) metrics and incident cardiovascular disease (CVD) including different subtypes [coronary heart disease (CHD), stroke, and sudden death], and all-cause mortality in an Iranian ...
Farzad Hadaegh   +6 more
doaj   +1 more source

Association between C-reactive protein with all-cause mortality in ELSA-Brasil cohort [PDF]

open access: yes, 2020
Background: High-sensitive C-reactive protein (hsCRP) has been proposed as a marker of incident cardiovascular disease and vascular mortality, and it may also be a marker of non-vascular mortality.
Alvim Matos, Sheila M.   +10 more
core   +3 more sources

Ideal Cardiovascular Health in the southern cone of Latin America [PDF]

open access: yesPublic Health, 2018
The American Heart Association developed the concept of 'Ideal Cardiovascular Health', which is based on the presence of ideal levels across seven health factors. The goal of this study is to assess the prevalence of Ideal Cardiovascular Health in the Southern Cone of Latin America.We conducted a cross-sectional analysis as part of CESCAS I cohort.This
Seron, P.   +9 more
openaire   +3 more sources

Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study [PDF]

open access: yes, 2015
Background: Olive oil (OO) consumption is associated with cardiovascular disease prevention because of both its oleic acid and phenolic contents. The capacity of OO phenolics to protect against low-density lipoprotein (LDL) oxidation is the basis for a ...
Altman   +47 more
core   +1 more source

Targeted, structured text messaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis (KIDNEYTEXT): Study protocol for a randomised controlled trial [PDF]

open access: yes, 2019
Introduction Managing nutrition is critical for reducing morbidity and mortality in patients on haemodialysis but adherence to the complex dietary restrictions remains problematic.
Brown, Mark   +12 more
core   +1 more source

Prevalence and associated factors of ideal cardiovascular health: A cross-sectional national population-based study of adults in the Marshall Islands

open access: yesPopulation Medicine, 2022
Introduction This study aimed to determine the prevalence, distribution, and correlates of ideal cardiovascular health (CVH) among adults in Marshall Islands.
Supa Pengpid, Karl Peltzer
doaj   +1 more source

Early infant feeding and adiposity risk: from infancy to adulthood [PDF]

open access: yes, 2014
Introduction: Systematic reviews suggest that a longer duration of breast-feeding is associated with a reduction in the risk of later overweight and obesity.
Beilin, L J   +10 more
core   +2 more sources

Association of sarcopenia with ideal cardiovascular health metrics among US adults: a cross-sectional study of NHANES data from 2011 to 2018

open access: yesBMJ Open, 2022
Objective The American Heart Association (AHA) proposed the concept of ideal cardiovascular health (CVH) to reduce the risk of cardiovascular mortality. We attempted to broaden the impact of CVH and further contribute to AHA 2030 goals by identifying the
Weihua Chen   +6 more
semanticscholar   +1 more source

Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease

open access: yesHeart, 2021
Objective Increasing number of clinical guidelines are adopting comprehensive cardiovascular risk assessment tools for treatment decision and disease management. Yet, little is known regarding cardiovascular risks associated with the length of favourable cardiometabolic profile.
So Mi Jemma Cho   +5 more
openaire   +3 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy